Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2024-04-04 00:00:00 ET · period of report 2024-04-01 · accession 0001127602-24-012486 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-04-04 | 2024-04-01 | DNA | Dmytruk Mark E. | See remarks | M - OptEx | — | +108.1K | 873.6K | +14% | — |
| D | 2024-04-04 | 2024-04-02 | DNA | Dmytruk Mark E. | See remarks | S - Sale+OE | $1.05 | -51.2K | 865.1K | -6% | -$53.7K |
| DM | 2024-04-04 | 2024-04-01 | DNA | Dmytruk Mark E. | See remarks | M - OptEx | — | -108.1K | 712.4K | -13% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-04-01 | M | A | 1,634 | — | 916,248 | D | — | — | (F3) Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. |
| 2 | Common | Class A Common Stock | 2024-04-01 | M | A | 22,916 | — | 914,614 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. |
| 3 | Common | Class A Common Stock | 2024-04-01 | M | A | 18,125 | — | 891,698 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. |
| 4 | Common | Class A Common Stock | 2024-04-02 | S | D | 51,169 | $1.05 | 865,079 | D | — | — | |
| 5 | Common | Class A Common Stock | 2024-04-01 | M | A | 65,448 | — | 873,573 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. |
| 6 | Derivative | Class B Common Stock | 2024-04-01 | M | D | 1,634 | — | 628,685 | D | — · — to — | 1,634 Class A Common Stock | (F7) Includes shares of Class B Common Stock that are subject to vesting conditions. (F3) Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. |
| 7 | Derivative | Restricted Stock Units | 2024-04-01 | M | D | 22,916 | — | 1,077,084 | D | — · — to — | 22,916 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F6) The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. |
| 8 | Derivative | Restricted Stock Units | 2024-04-01 | M | D | 18,125 | — | 634,375 | D | — · — to — | 18,125 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F5) The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. |
| 9 | Derivative | Restricted Stock Units | 2024-04-01 | M | D | 65,448 | — | 712,436 | D | — · — to — | 65,448 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. |